Trial Profile
Doripenem versus piperacillin/tazobactam in patients with nosocomial pneumonia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Doripenem (Primary) ; Piperacillin/tazobactam
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Registrational; Therapeutic Use
- 05 Nov 2010 New trial record.